European Journal of Breast Health
Original Article

Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer

1.

Department of Psychiatry, İstanbul Erenköy Training and Research Hospital, İstanbul, Turkey

2.

İstanbul Florence Nightangale Hospital, Breast Health Center, İstanbul, Turkey

3.

Department of General Surgery, İstanbul Taksim Training and Research Hospital, İstanbul, Turkey

4.

Department of Physiotherapy and Rehabilitation, İstanbul Bilgi University Faculty of Health Sciences, İstanbul, Turkey

5.

Gayrettepe Florence Nightingale Hospital, Breast Health Center, İstanbul, Turkey

6.

Department of General Surgery, Biruni University School of Medicine, İstanbul, Turkey

7.

Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey

Eur J Breast Health 2020; 16: 219-225
DOI: 10.5152/ejbh.2020.5259
Read: 65 Downloads: 36 Published: 24 June 2020

Objective: In the phase of diagnosis and treatment of breast cancer cases, patients can usually experience sexual dysfunctions, sleep disorders and psychiatric disorders such as anxiety and depression. The main objective of our research is to study of the pre-treatment and post-treatment anxiety, depression, sleep and sexual function levels in the patients with breast cancer.

Materials and Methods: Fifty-six patients with breast cancer and 52 healthy women have participated in our study. In order to determine the anxiety, depression, sleep and sexual function levels, Sociodemographic and Clinical Data Form, Hospital Anxiety Depression Scale (HADS), Pittsburgh Sleep Quality Scale (PSQI) and Arizona Sexual Experiences Scale (ASEX) scores are utilized at pre-treatment and post-treatment phases for patients with breast cancer and our control group.

Results: According to scale scores applied to patients and control group, it has been determined that patients with breast cancer HADS sexual and sleep disorders, that their HADS and PSQI scores were higher and that ASEX scores decreased significantly (p<0.05). According to the scale scores calculated before and after treatment, there was a significant decrease in HADS and PSQI scores, whereas SEX scores have been increased significantly (p<0.05).

Conclusion: According to the findings of our study, anxiety, depression, sexual dysfunction and sleep disorders in patients with breast cancer are far more explicit in the pre-treatment phase than post-treatment phase. Therefore, it is crucial to psycho-socially support patients with breast cancer in the early periods before starting the treatment after diagnosis.

Cite this articles as: İzci F, Özdem G, İlgün AS, Ağaçayak F, Duymaz T, Erdoğan Z, et al. Pre-Treatment and Post-Treatment Anxiety, Depression, Sleep and Sexual Function Levels in Patients with Breast Cancer. Eur J Breast Health 2020; 16(3): 219-225.

Files
EISSN 2587-0831